<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Responses have been reported in patients with <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) after low-dose <z:chebi fb="0" ids="28680">cytarabine</z:chebi> (Ara-C) or <z:chebi fb="0" ids="6067">13-cis-retinoic acid</z:chebi> (13-CRA) therapy </plain></SENT>
<SENT sid="1" pm="."><plain>Recently, combination of these two substances in vitro was shown to produce a synergistic effect on differentiation of leukemic cells </plain></SENT>
<SENT sid="2" pm="."><plain>We conducted a phase II trial with low-dose Ara-C (5 mg/m2 per 12 h s.c.) and 13-CRA (60 mg/m2 per day orally) in 14 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, six of whom had <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with excess of blasts (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>), seven had <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> in transformation (RAEBt) and one <z:hpo ids='HP_0011010'>chronic</z:hpo> myelomonocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e>) </plain></SENT>
<SENT sid="3" pm="."><plain>The drugs were administered from day 1 to 14 and the treatment courses repeated every 4 to 8 weeks </plain></SENT>
<SENT sid="4" pm="."><plain>One partial response and one minor response could be achieved </plain></SENT>
<SENT sid="5" pm="."><plain>Major toxicity included <z:hpo ids='HP_0000958'>dry skin</z:hpo>, mucositis and <z:hpo ids='HP_0100825'>cheilitis</z:hpo> in 11 of the 14 patients </plain></SENT>
<SENT sid="6" pm="."><plain>The response rate is no better than the results reported in the literature with either drugs alone </plain></SENT>
<SENT sid="7" pm="."><plain>As yet there is no satisfactory treatment for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
</text></document>